Indivior Pharmaceuticals Inc
Indivior Pharmaceuticals Inc (INDV) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
indv · stock forecast · 3 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 3 Wall Street analysts in the past 3 months
Buy
3 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$50.00
Consensus
$49.00
+30.2% upside
Low
$48.00
Median: $49 · Last Close: $37.62
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$49.00
30.2% upside
High Target
$50
32.9%
Low Target
$48
27.6%
Current Price
$37.62
as of today
Based on analyst price targets, the INDV stock price prediction for the next 12 months ranges from $48 to $50. The consensus INDV price forecast of $49.00 implies 30.2% upside from the current price of $37.62.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $36.68 | ↓ 2.50% |
1-day model range: $36.5–$36.86. Peak: $36.86 (-2.50%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $49 | +30.3% |
| 2028 | $58 | +54.0% |
| 2029 | $64 | +70.9% |
| 2030 | $68 | +82.1% |
| 2031 | — | +89.2% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · INDV · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-01-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-10-31 | Piper Sandler | Maintains | Overweight→Overweight |
| 2025-10-30 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-27 | Craig-Hallum | Maintains | Buy→Buy |
| 2025-06-30 | Craig-Hallum | Maintains | Buy→Buy |
| 2025-03-06 | Piper Sandler | Maintains | Overweight→Overweight |
| 2024-10-25 | Piper Sandler | Maintains | Overweight→Overweight |
| 2024-10-11 | Piper Sandler | Maintains | Overweight→Overweight |
| 2024-10-11 | Craig-Hallum | Maintains | Buy→Buy |
| 2024-09-13 | Piper Sandler | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Indivior Pharmaceuticals Inc (INDV) stock. Of the recent 11 rating actions, 0 were upgrades and 0 were downgrades. 3 analysts currently cover INDV.
Analyst Recommendation Trends
INDV analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$1.2B
↓ 10.1% YoY
Revenue Next Year
$1.3B
↑ 4.3% YoY
EPS This Year
$3.49
EPS Next Year
$3.81
↑ 9.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast INDV EPS of $3.49 for the current fiscal year, based on estimates from 2 analysts. The INDV revenue forecast is $1.2B for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The INDV stock forecast is supported by two independent data sources: analyst consensus ratings from 3 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus INDV price target is $49.00 (+30.2% upside), with an analyst consensus of Buy.
The INDV short-term stock prediction for tomorrow is $36.68 (-2.50%). The INDV stock price prediction for 2027 estimates an average of $49. The INDV stock prediction for 2030 projects a range of $65–$72.
Indivior Pharmaceuticals Inc trades on NASDAQ under the ticker INDV. The INDV stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
INDV forecast · 8 questionsAccording to 3 Wall Street analysts, the average 12-month INDV price target is $49.00, with a high forecast of $50.00 and a low of $48.00. The median price target is shown in the chart above when available. This implies +30.2% potential upside from the current price of $37.62.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.